Filter Results:
(4,683)
Show Results For
- All HBS Web
(4,683)
- People (16)
- News (1,871)
- Research (2,256)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,839)
Show Results For
- All HBS Web
(4,683)
- People (16)
- News (1,871)
- Research (2,256)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,839)
- 13 Mar 2023
- Research & Ideas
The Power of Personal Connections: How Shared Experiences Boost Performance
residency, including on metrics such as patients’ likelihood of recommending their specialist, write Maximilian J. Pany, a doctoral candidate at Harvard Business School and MD candidate at Harvard Medical School, and J. Michael McWilliams, Warren Alpert Foundation... View Details
- 07 Jun 2014
- Video
Ebru Dorman - Making A Difference
- June 1999 (Revised May 2000)
- Case
EndoSonics
EndoSonics is a manufacturer of a sophisticated medical device--a catheter that can take ultrasonic images within the blood vessels of the heart. The company deals with a series of challenges that relate to implementing a difficult technology in the face of a complex... View Details
Keywords: Information Technology; Distribution; Decision Choices and Conditions; Corporate Strategy; Entrepreneurship; Health Care and Treatment; Problems and Challenges; Manufacturing Industry; Medical Devices and Supplies Industry
Roberts, Michael J., and Diana S. Gardner. "EndoSonics." Harvard Business School Case 899-262, June 1999. (Revised May 2000.)
- June 1994 (Revised March 1995)
- Case
Lotus Development Corp.: Spousal Equivalents (A)
A group of Lotus employees propose extending all health care and other benefits to the spousal equivalents of lesbian and gay employees. The vice president of human resources considers the proposal during a reorganization and period of financial uncertainty. View Details
Gentile, Mary C., and Sarah Gant. "Lotus Development Corp.: Spousal Equivalents (A)." Harvard Business School Case 394-197, June 1994. (Revised March 1995.)
- 23 Jan 2020
- News
Five Ways Hospitals Will Change in Next Decade
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- 27 Aug 2013
- First Look
First Look: August 27
https://www.hbs.edu/faculty/Pages/item.aspx?num=45271 August 2013 Journal of Health Economics Consumers' Misunderstanding of Health Insurance By: Loewenstein, George, Joelle Y. Friedman, Barbara McGill, Sarah... View Details
Keywords: Sean Silverthorne
- 27 Nov 2017
- News
Payment Reform Is a Play We’re All Watching
- 01 Jul 2020
- News
How to Build an ESG Portfolio – And Why You Should
- 24 Apr 2019
- News
The Fallacy of Medicare for All
- 23 Feb 2017
- News
The power — and the fear — of knowing your cancer genome
- 03 Feb 2015
- Working Paper Summaries
Regulator Leniency and Mispricing in Beneficent Nonprofits
- 18 Dec 2017
- News
Hospital Giants Vie for Patients in Effort to Fend Off New Rivals
- 17 Dec 2007
- Research & Ideas
The Rise of Medical Tourism
describes, the globalization of health care also provides a fascinating angle on globalization generally and is of great interest to corporate strategists. "Apollo Hospitals—First-World View Details
- September 8, 2020
- Article
Allocation of COVID-19 Relief Funding to Disproportionately Black Counties
By: Pragya Kakani, Amitabh Chandra and Sendhil Mullainathan
This study describes correlations between the dollar amount of relief funding authorized by the US Congress to fund prevention, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) and to reimburse health care entities for lost revenues, and county-level... View Details
Kakani, Pragya, Amitabh Chandra, and Sendhil Mullainathan. "Allocation of COVID-19 Relief Funding to Disproportionately Black Counties." JAMA, the Journal of the American Medical Association 324, no. 10 (September 8, 2020): 1000–1003.
- 06 Apr 2021
- News